The "Montreal TransMedTech Institute" in Biomedical Engineering and Medical Technology

生物医学工程和医疗技术领域的“蒙特利尔 TransMedTech 学院”

• 批准号: CFREF-2015-00008
• 负责人: Brais, Augustin
• 金额: $ 250.93万
• 依托单位: École Polytechnique de Montréal
• 依托单位国家: 加拿大
• 项目类别: Canada First Research Excellence Fund
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=729405
• 关键词: Montreal; TransMedTech; Institute; Biomedical; Engineering

Over the past decades, Polytechnique Montréal has established an interdisciplinary group of Life Sciences and Engineering experts who have been leading the development of cutting-edge technologies in the biomedical engineering and medical technology sectors. This sustainable and successful model is based on the creation and maintenance of strong ties with a large hospital network (CHU Sainte-Justine, Centre Hospitalier de l'Université de Montreal, Montreal Heart Institute, Jewish General Hospital) within the Montreal area, as well as with international institutional and industrial partners to provide health innovative solutions for complex diseases, that could be tested and implemented within the healthcare system.We will take advantage of this transformative integrated university-hospital-industry framework to shape the future of medical technologies through the creation of the Montreal TransMedTech Institute, a transdisciplinary, transversal and translational initiative aiming at engineering the next generation of diagnostic/prognostic, intervention/rehabilitation and medical technologies for a spectrum of complex diseases across all age groups.The Canada First Research Excellence Fund investment will enable Polytechnique to consolidate and further develop the implementation of an outstanding integrative biomedical engineering research initiative based on a transversal approach spanning from the health problem to the most efficient development and implementation of the technologies with a “living lab” approach. This co-creation space with contributions from patients, caregivers, engineers, clinicians, applied/fundamental research scientists, students, health system stakeholders, and policy makers will be implemented from the inception to the development, implementation and assessment of new medical technologies, ensuring that innovations meet real needs with reduced technology transfer obstacles.

在过去的几十年里，蒙特利尔理工学院建立了一个由生命科学和工程专家组成的跨学科小组，他们一直在引领生物医学工程和医疗技术领域的尖端技术的发展。这种可持续和成功的模式是建立在与大型医院网络建立和保持牢固联系的基础上的（CHU Sainte-Justine，Centre Hospitalier de l 'Université de Montreal，Montreal Heart Institute，Jewish General Hospital），并与国际机构和行业合作伙伴合作，为复杂疾病提供创新的健康解决方案，我们将利用这一变革性的综合大学-医院-行业框架，通过创建蒙特利尔TransMedTech研究所，一个跨学科的，旨在设计下一代诊断/预后的横向和转化倡议，干预/加拿大第一卓越研究基金的投资将使理工学院能够巩固和进一步发展实施一项杰出的综合生物医学工程研究倡议，该倡议基于一种横向方法，从健康问题到最有效的技术开发和实施，采用“生活实验室”方法。这一共同创造空间将由患者、护理人员、工程师、临床医生、应用/基础研究科学家、学生、卫生系统利益相关者和政策制定者贡献，从新医疗技术的开发、实施和评估的开始，确保创新满足真实的需求，减少技术转让障碍。